Pacifica Partners Inc. Novo Nordisk A S Transaction History

Pacifica Partners Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$90.94 - $199.54 $21,825 - $47,889	240 Added 100.0%	480 $43,000
Q1 2023 Apr 11, 2023	SELL	$132.34 - $159.14 $29,776 - $35,806	-225 Reduced 48.39%	240 $38,000
Q3 2022 Oct 14, 2022	SELL	$95.28 - $116.93 $6,002 - $7,366	-63 Reduced 11.93%	465 $46,000
Q2 2022 Jul 22, 2022	BUY	$103.24 - $121.81 $48,006 - $56,641	465 Added 738.1%	528 $58,000
Q2 2021 Jul 14, 2021	BUY	$67.66 - $84.76 $4,262 - $5,339	63 New	63 $5,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Pacifica Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Pacifica Partners Inc. with notifications on news.